Side-by-side comparison of AI visibility scores, market position, and capabilities
Clinically validated XR therapeutic applications with FDA 510(k) clearances for rehabilitation and mental health. Boston MA; founded 2016; covers stroke recovery, TBI, Parkinson's, autism, and PTSD; prescribable by licensed clinicians and billable through health insurance plans.
XRHealth is a digital therapeutics company headquartered in Boston, Massachusetts, that develops clinically validated extended reality (XR) applications for medical rehabilitation and mental health treatment. Founded in 2016, XRHealth holds FDA 510(k) clearances for several of its XR therapeutic applications, a distinction that separates it from general wellness VR products and enables its applications to be prescribed by licensed clinicians and billed through health insurance. The company's platform spans rehabilitation for neurological conditions (stroke recovery, traumatic brain injury, Parkinson's disease), musculoskeletal rehabilitation, and cognitive and mental health interventions, all delivered through consumer-grade VR headsets in clinical settings or the patient's home.\n\nXRHealth's platform combines therapeutic XR applications with a clinical intelligence layer that captures patient performance data during each session—motion range, reaction time, cognitive accuracy, and engagement metrics—and presents it through a clinician portal for remote monitoring and treatment plan adjustment. This telehealth-integrated model enables physical therapists, occupational therapists, and neurologists to prescribe XR therapy programs and monitor patient progress asynchronously, extending the reach of rehabilitation services beyond clinic walls. The company partners with hospital systems, rehabilitation centers, and insurance providers to integrate XR therapy into standard care pathways.\n\nXRHealth competes with AppliedVR, Penumbra's REAL System, and MindMaze in the clinical XR therapeutics market. Its FDA-cleared product portfolio, insurance reimbursement progress, and clinician-facing data platform distinguish it from consumer wellness VR tools and position it as a credentialed medical technology company. For healthcare providers and payers seeking technology-enabled rehabilitation solutions that can demonstrate clinical outcomes and integrate into existing care management workflows, XRHealth offers one of the most clinically validated XR therapy platforms commercially available.
Sony (NYSE: SONY) gaming platform with 135M+ PSN users, 47M+ PlayStation Plus subscribers at $25B+ FY2024 segment revenue; PS5 exclusive franchises competing with Microsoft Xbox Game Pass for console gaming market leadership.
PlayStation is the gaming brand of Sony Group Corporation (TYO: 6758 / NYSE: SONY) — the global consumer electronics and entertainment conglomerate generating ¥13+ trillion ($88B+) in annual revenue — operating the PlayStation 5 console platform (110M+ PS5 units sold by 2025), PlayStation Network (135M+ monthly active users), PlayStation Plus subscription service (47M+ paid subscribers across Essential, Extra, and Premium tiers), and PlayStation Studios (19 first-party game studios producing exclusive franchises including God of War, Spider-Man/Marvel, Horizon, The Last of Us, Gran Turismo, and Ghost of Tsushima). Sony's game and network services segment generated approximately $25 billion+ in revenue in fiscal year 2024, making it the largest revenue segment within Sony Group and the second-largest gaming platform by revenue after Microsoft's Xbox/Activision combined entity.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.